Send Message
View as an RSS Feed
  • Northwest: FDA hasn't agreed main endpoint for DCVax trial  [View news story]
    Sounds like a "standard disclaimer" that should be in a 10-K. There are no guarantees at this point otherwise NWBO would be sitting at $300 right now.
    Apr 3, 2014. 09:37 AM | 3 Likes Like |Link to Comment
  • Gold Will Offer Protection When Stocks Decline  [View article]
    So according to your article, gold will decline when the overall market will decline, and gold will rally when the overall market will decline. Which one is it?
    Aug 9, 2013. 03:08 AM | Likes Like |Link to Comment
  • Much Ado About Apple: Why The Pessimists Are Wrong  [View article]
    A Peg Ratio of .58 (according to this article) and a dividend yield of more than 2% "screams" BUY to me. How many companies with dividend yields over 2% trade at a PE of 11.5? Buy on the next dip down to $505. Hold through earnings.
    Jan 6, 2013. 04:41 AM | Likes Like |Link to Comment
  • Billionaire T. Boone Pickens' Top Stock Picks  [View article]
    Cramer sold off Devon last week in his Charitable fund. He is putting his money in SWN.
    Nov 25, 2012. 05:10 PM | Likes Like |Link to Comment
  • Merrimack IPO: Repackaging And Refining Chemotherapy  [View article]
    Here is another small company, CYTR, which is an Oncology company working to increase the positive effects of chemotherapy by increasing the dosage dramatically with no additional side effects. Products have a linker which targets the tumor itself. Positive PhaseI/II results so far.
    Feb 23, 2012. 03:57 AM | Likes Like |Link to Comment
  • 10 Biotech Stocks With Big Potential Upside In 2012: Part III  [View article]
    What do you think of CYTR? Great Phase I results, very ecouraging phase II so far. Nothing but good press releases for more than eighteen months now.
    Feb 23, 2012. 01:12 AM | Likes Like |Link to Comment
  • Why CytRx Corporation Is Still A Big Biotech 'If' Play  [View article]
    Just wanted to say thanks to the short sellers for driving this stock down to < .26 per share so I could buy a nice chunk of stock at a great price. Check out the latest press release, international testing as a "first line therapy". This is beginning to get very interesting. Forget the past, this company is focused and making considerable progress as an oncology company.
    Dec 28, 2011. 10:38 PM | 2 Likes Like |Link to Comment
  • Why CytRx Corporation Is Still A Big Biotech 'If' Play  [View article]
    It is easy to pick apart the past at CYTR. That said, since the focus has turned strictly to oncology, this company has been turning in one impressive story after another. The pipeline is simply too far off in the future for most investors to get excited about this company right now. And then investors will begin to worry if there is enough cash to carry them through all of their phase II trials into phase III? The price estimates over $1.50 reflect a price at the end of phase II trials with perhaps a partner or two. This company needs partners to drive the stock price up in the near term, if not, this stock could easily drop into the teens before recovering. CYTR is focused and if the positive news stories keep coming ...................
    Dec 14, 2011. 11:18 PM | Likes Like |Link to Comment
  • Libya's Oil Comes Back Online: Opportunities Abound  [View article]
    no mention of Apache?
    Nov 15, 2011. 01:20 AM | Likes Like |Link to Comment
  • 4 Small-Cap Technology Companies With Bullish Insider Buying  [View article]
    it would be helpful if you posted the actual purchase dates of the stock and link to this information.
    Jun 12, 2011. 10:46 PM | Likes Like |Link to Comment
  • Energy Conversion Devices Warning Is Negative for Solar Stocks  [View article]
    Why was SOLR mentioned in this article? What does SOLR have to do with Italy? Isn't SOLR the contrarian play on most other solar stocks?
    Mar 14, 2011. 03:08 AM | Likes Like |Link to Comment
  • China Sun Group High Tech: A Deep Value Play  [View article]
    Dear Author,

    How long have you been long this stock? What is your cost basis? What is your target price based on realistic production increases?
    Jan 23, 2011. 02:54 PM | Likes Like |Link to Comment
  • Uncovering the Real Problem With Chinese Reverse Takeovers  [View article]
    Hey Dutch Trader,

    What do you think of TRIT? I believe this was a reverse merger.
    Jan 19, 2011. 06:47 PM | Likes Like |Link to Comment
  • China MediaExpress: The Burden of a Low Share Price  [View article]
    You said in the article you were not holding a position. Does this stock trade in conjunction with the SSE considering this is an ADR? Seems like this stock has been in a significant downtrend , has the SSE declined significantly over the same period?
    Sep 19, 2010. 07:18 PM | Likes Like |Link to Comment
  • China MediaExpress: The Burden of a Low Share Price  [View article]
    All those positive comments and you are not "long" the stock. What is holding you back personally from buying the stock?
    Sep 19, 2010. 02:08 PM | 1 Like Like |Link to Comment